Buckingham Capital Management, Inc. Johnson & Johnson Transaction History

Buckingham Capital Management, Inc.

$863 Million
Q3 2024

A detailed history of Buckingham Capital Management, Inc. transactions in Johnson & Johnson stock. As of the latest transaction made, Buckingham Capital Management, Inc. holds 12,071 shares of JNJ stock, worth $1.88 Million. This represents 0.23% of its overall portfolio holdings.

Number of Shares

12,071

Previous 12,089 0.15%

Holding current value

$1.88 Million

Previous $1.77 Million 10.76%

% of portfolio

0.23%

Previous 0.21%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 04, 2024	SELL	$145.48 - $167.38 $2,618 - $3,012	-18 Reduced 0.15%	12,071 $1.96 Million
Q2 2024 Jul 15, 2024	BUY	$144.38 - $157.78 $8,085 - $8,835	56 Added 0.47%	12,089 $1.77 Million
Q1 2024 Apr 10, 2024	BUY	$155.22 - $162.74 $69,538 - $72,907	448 Added 3.87%	12,033 $1.9 Million
Q4 2023 Feb 07, 2024	BUY	$145.6 - $158.88 $128,419 - $140,132	882 Added 8.24%	11,585 $1.82 Million
Q3 2023 Oct 13, 2023	BUY	$155.75 - $174.48 $101,393 - $113,586	651 Added 6.48%	10,703 $1.67 Million
Q2 2023 Jul 11, 2023	BUY	$154.35 - $166.11 $121,164 - $130,396	785 Added 8.47%	10,052 $1.66 Million
Q1 2023 Apr 11, 2023	BUY	$151.05 - $180.26 $237,601 - $283,548	1,573 Added 20.44%	9,267 $1.44 Million
Q4 2022 Jan 24, 2023	SELL	$160.2 - $179.79 $22,107 - $24,811	-138 Reduced 1.76%	7,694 $0
Q3 2022 Nov 10, 2022	BUY	$161.33 - $179.52 $40,655 - $45,239	252 Added 3.32%	7,832 $1.28 Million
Q2 2022 Aug 05, 2022	BUY	$168.19 - $186.01 $42,552 - $47,060	253 Added 3.45%	7,580 $1.35 Million
Q1 2022 May 06, 2022	SELL	$158.14 - $179.59 $43,330 - $49,207	-274 Reduced 3.6%	7,327 $1.3 Million
Q4 2021 Feb 07, 2022	BUY	$155.93 - $173.01 $4,210 - $4,671	27 Added 0.36%	7,601 $1.3 Million
Q3 2021 Nov 08, 2021	BUY	$161.5 - $179.47 $2,099 - $2,333	13 Added 0.17%	7,574 $1.22 Million
Q2 2021 Jul 27, 2021	SELL	$159.48 - $171.07 $25,516 - $27,371	-160 Reduced 2.07%	7,561 $1.25 Million
Q1 2021 May 04, 2021	BUY	$153.07 - $170.48 $55,105 - $61,372	360 Added 4.89%	7,721 $1.27 Million
Q4 2020 Feb 04, 2021	SELL	$137.11 - $157.38 $193,187 - $221,748	-1,409 Reduced 16.07%	7,361 $1.16 Million
Q3 2020 Nov 02, 2020	SELL	$140.38 - $153.83 $329,050 - $360,577	-2,344 Reduced 21.09%	8,770 $1.31 Million
Q2 2020 Jul 20, 2020	SELL	$128.81 - $155.51 $395,704 - $477,726	-3,072 Reduced 21.66%	11,114 $1.56 Million
Q1 2020 May 06, 2020	SELL	$111.14 - $153.99 $933,464 - $1.29 Million	-8,399 Reduced 37.19%	14,186 $1.86 Million
Q4 2019 Feb 13, 2020	SELL	$127.5 - $146.44 $715,402 - $821,674	-5,611 Reduced 19.9%	22,585 $3.29 Million
Q3 2019 Nov 12, 2019	SELL	$126.95 - $142.14 $844,217 - $945,230	-6,650 Reduced 19.08%	28,196 $3.65 Million
Q2 2019 Aug 09, 2019	SELL	$131.15 - $144.24 $1.67 Million - $1.84 Million	-12,734 Reduced 26.76%	34,846 $4.85 Million
Q1 2019 May 07, 2019	SELL	$125.72 - $139.79 $1.12 Million - $1.25 Million	-8,918 Reduced 15.78%	47,580 $6.65 Million
Q4 2018 Feb 04, 2019	SELL	$122.84 - $147.84 $212,021 - $255,171	-1,726 Reduced 2.96%	56,498 $7.29 Million
Q3 2018 Nov 20, 2018	SELL	$121.58 - $142.88 $389,663 - $457,930	-3,205 Reduced 5.22%	58,224 $8.05 Million
Q2 2018 Aug 10, 2018	BUY	$119.4 - $131.76 $32,357 - $35,706	271 Added 0.44%	61,429 $7.45 Million
Q1 2018 May 11, 2018	BUY	$125.1 - $148.14 $154,873 - $183,397	1,238 Added 2.07%	61,158 $7.84 Million
Q4 2017 Feb 13, 2018	BUY	$131.22 - $143.62 $97,890 - $107,140	746 Added 1.26%	59,920 $8.37 Million
Q3 2017 Nov 07, 2017	BUY	$129.47 - $135.38 $72,762 - $76,083	562 Added 0.96%	59,174 $7.69 Million
Q2 2017 Aug 10, 2017	BUY	N/A	58,612	58,612 $7.75 Million

Others Institutions Holding JNJ

# of Institutions

4,272

Shares Held

1.68B

Call Options Held

17.6M

Put Options Held

14.5M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $406B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Buckingham Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Buckingham Capital Management, Inc. with notifications on news.

Account

Buckingham Capital Management, Inc. Johnson & Johnson Transaction History